State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases

Author(s): Mark A. Babizhayev, Anne Kasus-Jacobi

Journal Name: Current Clinical Pharmacology
Continued as Current Reviews in Clinical and Experimental Pharmacology

Volume 4 , Issue 1 , 2009

Become EABM
Become Reviewer
Call for Editor


Full text svailable

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [4 - 37]
Pages: 34
DOI: 10.2174/157488409787236074

Article Metrics

PDF: 53